E. Schrade

Influence of Institutional Experience and Technological Advances on Outcome of Stereotactic Body Radiation Therapy for Oligometastatic Lung Disease.

L. Uhlmann, F. Lohr, M. Eble, 2017, International journal of radiation oncology, biology, physics.

Long-term Follow-up and Patterns of Recurrence of Patients With Oligometastatic NSCLC Treated With Pulmonary SBRT.

L. Uhlmann, M. Duma, G. Hildebrandt, 2019, Clinical lung cancer.

Nomogram based overall survival prediction in stereotactic body radiotherapy for oligo-metastatic lung disease.

M. Eble, M. Duma, F. Sterzing, 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Stereotactic body radiotherapy (SBRT) for multiple pulmonary oligometastases: Analysis of number and timing of repeat SBRT as impact factors on treatment safety and efficacy.

M. Eble, M. Duma, T. Wendt, 2018, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Stereotactic body radiotherapy (SBRT) for medically inoperable lung metastases-A pooled analysis of the German working group "stereotactic radiotherapy".

L. Uhlmann, M. Eble, M. Duma, 2016, Lung cancer.

The impact of local control on overall survival after stereotactic body radiotherapy for liver and lung metastases from colorectal cancer: a combined analysis of 388 patients with 500 metastases

R. Semrau, M. Eble, M. Duma, 2019, BMC Cancer.

The impact of local control on overall survival after stereotactic body radiotherapy for liver and lung metastases from colorectal cancer: a combined analysis of 388 patients with 500 metastases

R. Semrau, M. Eble, M. Duma, 2019, BMC cancer.